Brief: Idera Pharmaceuticals Reports Q3 Loss Per Share Of $0.39

Aceragen

06/11/2019 23:07

Nov 6 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND
REPORTS
THIRD QUARTER 2019 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.39
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.47 -- REFINITIV IBES
DATA
    * IDERA PHARMACEUTICALS - EXPECT EXISTING CASH, CASH
EQUIVALENTS
AND INVESTMENTS ON HAND AS OF SEPTEMBER 30, 2019, WILL FUND
OPERATIONS INTO Q3 OF 2020

Source text for Eikon:  ID:nGNX7C0lbl 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))